← Back to Search

Educational Course for Supporting LGBTQ+ Students (PLANTS Trial)

N/A
Waitlist Available
Led By Robert Coulter, PhD, MPH
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 years old or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 4 months after intervention deployment
Awards & highlights

PLANTS Trial Summary

This trial will test if a course can help high school staff better support LGBTQ+ students. It will measure how well it is accepted, used, appropriate, and feasible.

Who is the study for?
The PLANTS Pilot Trial is for high school staff members who are currently employed by a participating school in the MetroWest Region of Boston, Massachusetts. Participants must be at least 18 years old and willing to consent to take part in the study.Check my eligibility
What is being tested?
This trial is testing the PLANTS course designed for high school staff to address issues like depression, alcohol consumption, social acceptance, and bullying among LGBTQ+ adolescents. It's a pilot study comparing traditional communication (EMAILS) with the new PLANTS intervention.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects expected from participation. However, emotional or psychological responses could occur due to discussions about sensitive topics.

PLANTS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

PLANTS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 4 months after intervention deployment
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 4 months after intervention deployment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean score on the System Usability Scale
Mean value of Acceptability of Intervention Measure
Mean value of Feasibility of Intervention Measure
+1 more
Secondary outcome measures
Change in mean scores on PLANTS' self-efficacy change objectives
Change in mean scores on the Active-Empathic Listening Scale
Change in mean scores on the Teacher Bystander Intervention Model in Cyberbullying scale
+6 more

PLANTS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PLANTSExperimental Treatment1 Intervention
Schools will receive the online-delivered PLANTS intervention, which includes 3 asynchronous training modules and 3 synchronous group events.
Group II: EMAILSActive Control1 Intervention
Comparison schools will receive emails with publicly available resources for supporting LGBTQ+ students as a control intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PLANTS
2023
N/A
~100

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,731 Previous Clinical Trials
16,307,338 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
811 Previous Clinical Trials
1,158,188 Total Patients Enrolled
Robert Coulter, PhD, MPHPrincipal InvestigatorUniversity of Pittsburgh

Media Library

PLANTS Clinical Trial Eligibility Overview. Trial Name: NCT05897827 — N/A
Alcohol Consumption Research Study Groups: PLANTS, EMAILS
Alcohol Consumption Clinical Trial 2023: PLANTS Highlights & Side Effects. Trial Name: NCT05897827 — N/A
PLANTS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05897827 — N/A
~52 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top